Cargando…
The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
Photodynamic therapy (PDT) has emerged as an effective treatment for various solid tumors. The transcription factor NRF2 is known to protect against oxidative and electrophilic stress; however, its constitutive activity in cancer confers resistance to anti-cancer drugs. In the present study, we inve...
Autores principales: | Choi, Bo-hyun, Ryoo, In-geun, Kang, Han Chang, Kwak, Mi-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165896/ https://www.ncbi.nlm.nih.gov/pubmed/25226504 http://dx.doi.org/10.1371/journal.pone.0107158 |
Ejemplares similares
-
NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells
por: Choi, Bo-Hyun, et al.
Publicado: (2017) -
Intratumoral Photodynamic Therapy With Newly Synthesized Pheophorbide a in Murine Oral Cancer
por: Ahn, Mee-Young, et al.
Publicado: (2017) -
Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
por: Ryoo, In-geun, et al.
Publicado: (2015) -
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
por: Kim, Donghyeok, et al.
Publicado: (2018) -
Zinc-Substituted Pheophorbide A Is a Safe and Efficient Antivascular Photodynamic Agent
por: Szafraniec, Milena J., et al.
Publicado: (2022)